- Before
- Opens seven systems for every batch and finds the open item at the end of the review.
- Now
- Starts from a cited 18-line dossier with every blocker named, reads the notes, and signs.
One batch, from last QC result to certified
QC releases the last results for Veltrimab batch VL26-0418 at 07:52. It is needed at the EU distribution centre on Oct 9. Here is the QP’s morning, screen by screen, in the working solution.
- 01Morning
The release runway, before the first coffee
Lena Ortiz · Qualified PersonLena opens the desk at Plant 3 — Leiden: 8 batches in quarantine worth €63.6 M, 2 ready for her signature, 4 blockers, and 1 new dossier to assemble. The runway shows each batch from made to needed-by, with today and the forecast release. CR26-1102 is already flagged: its forecast of Oct 11 misses the Oct 9 need date, and the supply planner has been told.
“CR26-1102 will miss its Oct 9 need date at the current forecast — Priya Raman informed.”
- 0207:52
Results are in — the dossier is ready to assemble
Lena Ortiz · Qualified PersonVL26-0418: 48,210 prefilled syringes of Veltrimab 150 mg/mL for DE, FR, NL, ES and IT, needed Oct 9, €11.6 M held. The screen lays out what the dossier will check — 18 lines across batch record and process, QC results, deviations and investigations, changes, environment and utilities, materials and supply chain, and market and distribution — with the batch record review report already open beside it.
“Each line comes back met, met with a note for you to read, or a blocker with the person who can clear it. Agents never certify — the decision and the e-signature stay with you.”
- 0346 seconds
Six specialists read seven systems
Release coordinatorLena presses Assemble dossier. The coordinator sends each line to its specialist — MES, LIMS, the quality system, EM, ERP, the regulatory system and serialisation — and each step reports what it found: 214 steps signed with 3 exceptions dispositioned, 17 results against the registered specification, 1,284 EM samples with 1 Grade B excursion, closed. 112 records read, 24 citations, and the verdict: 15 met, 2 met with a note, 1 blocker, owner told.
“Verdict written — 1 blocker, 2 notes, 15 met · owners told.”
- 04The blocker
One deviation stands between the batch and certification
Deviation and change tracerDEV-26-1187, major: the stopper bowl on filling line FL-2 jammed, so the formulated bulk was held 26 h 40 min against the 24 h batch-record limit. The hold-time study VR-114 supports 36 h at 2–8 °C and the impact assessment concludes negligible impact — but QA approval is still pending, with Omar Haddad, due 12:00. The deviation report opens beside it, with the exact passage highlighted.
The tracer never marks a deviation closed — it cites the approval record, not the summary.
- 05Notes to read
A market dropped, an excursion explained
Deviation and change tracerVL26-0418 is the first batch with stoppers from the second-source supplier, lot WE-7731. Change control CC-26-0233 shows the EU type IB variation approved on Sep 2 and Canada filed Sep 18, approval pending — so the certificate covers the five EU markets only. A second note: settle plate B-07 in Grade B room F-214 read 6 CFU / 4 h against an action limit of 5 on the fill day; every Grade A sample read 0 CFU and the investigation closed Oct 3 with no impact.
“Destination markets DE · FR · NL · ES · IT are covered by the marketing authorisation and every change used. Canada is excluded until CC-26-0233 is approved there.”
- 0610:42
One chase, one approval, one line re-checked
Omar Haddad · QA operationsLena presses Ask Omar to approve; the message goes to Omar Haddad with DEV-26-1187 and the cited records. Omar approves the impact assessment — negligible impact, batch added to the ongoing stability programme — and the coordinator re-checks only the line his record touches. The dossier turns: ready to certify, 15 met, 3 with a note to review.
- 07Certify
She reads the notes, and signs
Lena Ortiz · Qualified PersonThe certify dialog states what she is certifying, lists the markets with Canada excluded, and will not let her sign until she ticks each note as reviewed — DEV-26-1187, CC-26-0233 and EM-26-0311. She chooses the meaning of the signature, Certified for release (Annex 16), and signs with her password.
“I certify that batch VL26-0418 of Veltrimab 150 mg/mL prefilled syringe has been manufactured and checked in compliance with the marketing authorisation and EU GMP (Directive 2001/83/EC Art. 51; Annex 16).”
- 0810:58
Certified, registered, released
Certification and releaseCertified Oct 7 at 10:58 by Lena Ortiz — QPC-2026-1043, two days before the need date. The register entry is written, the signed certificate is issued with her e-signature manifest, ERP stock moves from Quarantine to Unrestricted for DE, FR, NL, ES and IT, the pick list is released and Priya Raman in supply planning is told.
- 09On file
The certificate, drafted from the checklist
Certificate drafterThe certificate of batch certification lists the product, the batch, the markets covered — “not Canada (CC-26-0233 pending)” — the checklist outcome and the notes the QP reviewed. The drafter left the signature block for the QP; once signed it carries her name, the meaning and the time, and the entry sits in the certification register.